Allan 2005.
Study characteristics | |||
Patient sampling | Prospective; series of patients with same risk profile; consecutive enrollment not reported. Episode‐based analysis | ||
Patient characteristics and setting | 125 participants
Age ranged from 16 to 76 years
No information about gender
Scotland Adults undergoing allogeneic or autologous stem cell transplantation or intensive chemotherapy; no other details reported Representative spectrum? Unclear: adult haemato‐oncology patients |
||
Index tests | Platelia: twice‐weekly screening; different ways of defining positive result reported and different cut‐off values | ||
Target condition and reference standard(s) | Invasive aspergillosis, according to EORTC criteria (Ascioglu 2002) Incorporation avoided? Yes: as the Platelia Aspergillus was being evaluated it was excluded from the EORTC/MSG definitions Acceptable reference standard? Yes: IFI was classified as proven, probable or possible according to the EORTC/MSG definitions (Ascioglu 2002) |
||
Flow and timing | Timing not reported Partial verification avoided? Unclear: it was unclear if really all patients were classified using the reference criteria Withdrawals explained? No: not reported Uninterpretable results reported? No: there were no uninterpretable results |
||
Comparative | |||
No patients per category | 0 proven, 1 probable, 11 possible, 113 non‐IA | ||
Notes | Sponsoring: grants from Chief Scientists Office, Scotland, Wyeth Healthcare and Gilead Sciences | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Unclear | Unclear | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | No | ||
High | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Low | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Low |